Latest Trading Halts News

Austral Resources Australia has voluntarily suspended its shares on the ASX to complete a significant placement and secure a strategic investor commitment, with strong demand reported.

Chariot Resources Ltd has voluntarily suspended trading on the ASX as it finalises a significant financing arrangement, with an announcement expected by 20 February 2026.

Aumega Metals has voluntarily suspended its ASX securities as it finalises a capital raising involving a significant new investor. The suspension is expected to last until the capital raising is completed and announced, or until trading resumes on 19 February.

Bubalus Resources has responded to ASX concerns over a delayed director interest notice, attributing the lapse to an administrative oversight and reaffirming its commitment to compliance.

Marmota Limited has raised $15 million through a well-supported placement, aiming to fast-track exploration at its promising Gawler gold project. The capital injection comes with strong institutional backing and sets the stage for upcoming drilling campaigns.

Cobre Limited has voluntarily suspended its ASX trading to finalise details of a significant acquisition and placement, with an announcement expected imminently.

Great Dirt Resources has raised $1.446 million through a discounted share placement and appointed seasoned resource executives to drive its growth strategy.

Revolution Private Credit Income Trust has successfully raised $60 million through a wholesale placement, strengthening its capacity to invest in senior secured loans and asset-backed securities across Australia and New Zealand.

Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.

Tartana Minerals secures $4.5 million to ramp up exploration at its Nightflower Silver-Lead-Zinc-Antimony project and appoints a new director to bolster governance.

Revolution Private Credit Income Trust (REV) has announced a $60 million wholesale placement at $2.00 per unit, aiming to broaden its exposure to Australian and New Zealand private debt markets. The move is expected to enhance portfolio diversification and liquidity for unitholders.

Apiam Animal Health’s acquisition scheme by Adamantem Capital has been legally approved, leading to the suspension of its shares on the ASX. Key dates for dividend payments and scheme implementation are now set.